Express Topic (7.30pm-9pm)
The range of oral chemotherapy agents available and their use in patients has risen dramatically over the last number of years. Oral chemotherapy offers many benefits to patients in terms of use of administration and access, however it also carries the same risks as traditional chemotherapy.
The aim of this express course is to provide an update on the requirements on safe supply and handling of oral chemotherapy, as well focusing on newer agents available and considering patient factors such as adherence to therapy.
Pharmacists interact frequently with parents of babies and small children.
The aim of this course is to cover the main health concerns for parents of babies and small children. This includes information on the public health benefits of vaccination, the current vaccination schedule for babies up to 1 year and the management of common early childhood conditions.
With an ever increasing range of both prescribed and OTC medicines, pharmacists must be vigilant for the potential for Adverse Drug Reactions (ADR) and Drug Interactions.
The aim of this course is to provide information on common pathways such as the Glycoprotein P system and CYPT450 system where drug interactions are more likely to occur as well as the mechanisms of frequently reported drug interactions.
Medication safety is one of the key cornerstones for the profession of pharmacy. It is a key aspect of our daily pharmacy practice.
The aim of this course is to provide an update on medication safety issues and requirements and to facilitate best practice around medication safety in your practice.
There is increasing awareness of mental health issues that affect children and adolescents in Ireland. Often the community pharmacist is in an ideal position to support young people and their families.
The aim of this course is to provide an overview of some of the common mental health issues that affect children such as Autism, ADHD, depression, and eating disorders. It will also include information on non-drug and licenced drug treatments of these conditions, and their role in the overall management of these conditions.